Last checked at 14 Mar 2024 10:01
TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion
(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News2
AZN Share
Chat
AZN Share
Trades18,389
AZN
Live RNS1
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,118.00
Bid:
12,120.00
Ask:
12,124.00
Change:
68.00 (0.56%)
Spread:
4.00 (0.033%)
Open:
11,966.00
High:
12,162.00
Low:
11,966.00
Prev. Close:
12,050.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Friday broker round-up
Fri, 25th Jan 2019 13:21
(Sharecast News) - Fresnillo: UBS upgrades to buy with a target price of 1,100p.Daily Mail: Berenberg reiterates buy with a target price of 700p.Scapa Group: Berenberg reiterates buy with a target price of 520p.Sureserve Group: Peel Hunt upgrades to buy with a target price of 40p.Restaurant Group: Liberum reiterates hold with a target price of 180p.Burford Capital: Liberum reiterates buy with a target price of 2,300p.Astrazeneca: Shore Capital Markets downgrades to buy.Marston's: Canaccord reiterates hold with a target price of 105p.Quixant: Canaccord reiterates buy with a target price of 440p.Vodafone: RBC Capital Markets reiterates underperform with a target price of 144p.Connect Group: Berenberg reiterates hold with a target price of 40p.International Consolidated Airlines: Berenberg reiterates buy with a target price of 780p.
More News
14 Mar 2024 07:52
LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook
(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.
Read more14 Mar 2024 07:16
AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn
(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.
Read more8 Mar 2024 06:00
Astra, Sanofi's antibody 90% effective against RSV in infants - CDC
(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.
Read more6 Mar 2024 14:40
UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted
(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.
Read more5 Mar 2024 14:24
AstraZeneca's breast cancer treatment blocked for NHS use in England
(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.
Read more4 Mar 2024 09:31
AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment
(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.
Read more4 Mar 2024 07:18
AstraZeneca's chemo replacement treatment moves closer to EU approval
(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.
Read more26 Feb 2024 08:51
AstraZeneca's Voydeya treatment recommended for EU approval
(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.
Read more26 Feb 2024 07:22
AstraZeneca's blood-disorder drug recommended for EU approval
(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.
Read more22 Feb 2024 17:36
EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:
Read more20 Feb 2024 10:29
AstraZeneca acquires US-based biopharmaceutical company
(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.
Read more20 Feb 2024 09:40
LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:
Read more19 Feb 2024 16:51
LONDON MARKET CLOSE: Europe lacks direction on quiet Monday
(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.
Read more19 Feb 2024 15:59
London close: Stocks manage gains on globally quiet day
(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.
Read more